Supporting Shared Decision-Making and Home Dialysis in End-Stage Kidney Disease.

Int J Nephrol Renovasc Dis

Department of Medicine, North Florida/South Georgia Veteran Healthcare System, Gainesville, FL, USA.

Published: September 2022

AI Article Synopsis

  • Patient education and shared decision-making positively impact outcomes for chronic conditions like kidney disease, emphasizing the need for regulatory support on these practices.
  • The U.S. aims to boost home dialysis use, which can improve patient results and healthcare costs, aligning with the goals of shared decision-making.
  • The Nephrologist's Shared Decision-Making Checklist offers a user-friendly tool for providers, ensuring that they effectively collaborate with patients and caregivers in their treatment choices.

Article Abstract

It has been widely demonstrated that patient education and empowerment, especially involving shared treatment decisions, improve patient outcomes in chronic medical conditions, including chronic kidney disease requiring kidney replacement therapies. Accordingly, regulatory agencies in the US and worldwide recommend shared decision-making for finalizing one's choice of kidney replacement therapy. It is also recognized that the US needs to substantially increase home dialysis utilization to leverage its positive impacts on patient and healthcare cost-related outcomes. This perspective highlights how the routine clinical use of the recommended practice of shared decision-making can exist in synergy with the system's goal for increased home dialysis use. It introduces a pragmatic provider checklist, The Nephrologist's Shared Decision-Making Checklist, grounded in the relevant theories of shared decision-making, and, unlike some research assessments and extant tools, is easy to understand and implement in clinical practice. This qualitative Checklist can help providers ensure that they have co-constructed an SDM experience with the patient and involved caretakers, helping them benefit from the improved outcomes associated with SDM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467687PMC
http://dx.doi.org/10.2147/IJNRD.S375347DOI Listing

Publication Analysis

Top Keywords

shared decision-making
20
kidney disease
8
kidney replacement
8
decision-making
5
shared
5
supporting shared
4
decision-making dialysis
4
dialysis end-stage
4
kidney
4
end-stage kidney
4

Similar Publications

Objective: The objective of this study is to analyse the perspectives of screening candidates and healthcare professionals on shared decision-making (SDM) in prostate cancer (PCa) screening using the prostate-specific antigen (PSA) test.

Design: Descriptive qualitative study (May-December 2022): six face-to-face focus groups and four semistructured interviews were conducted, transcribed verbatim and thematically analysed using ATLAS.ti software.

View Article and Find Full Text PDF

Atrial fibrillation (AF) is the most common sustained arrhythmia, linked with a significantly heightened risk of stroke. While moderate exercise reduces AF risk, high-level endurance athletes paradoxically exhibit a higher incidence. However, their stroke risk remains uncertain due to their younger age, higher cardiovascular fitness, and lower rate of comorbidities.

View Article and Find Full Text PDF

Background: Rich data on diverse patients and their treatments and outcomes within Electronic Health Record (EHR) systems can be used to generate real world evidence. A health recommender system (HRS) framework can be applied to a decision support system application to generate data summaries for similar patients during the clinical encounter to assist physicians and patients in making evidence-based shared treatment decisions.

Objective: A human-centered design (HCD) process was used to develop a HRS for treatment decision support in orthopaedic medicine, the Informatics Consult for Individualized Treatment (I-C-IT).

View Article and Find Full Text PDF

The direct and indirect financial burden of cancer care, from medication costs to lost wages, results in financial toxicity for patients. Despite the growing recognition of financial toxicity as a problem for patients, there are few solutions available at the point of care. Structured cost conversations between oncologists and patients to help identify financial toxicity and intervene early when it is recognized have been posited as a patient facing intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!